Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
Nice spot CW.
9 months...pfft... Scancell will in the quids by then ;-)
"
- A useful Active licensing discussions ongoing.***⭐
- Scib-1 clearing bulky tumours.....fantastic
-Looking incredibly good that tumours are staying shrunk.
- Lindy "Stunning results"
- We EXPECT to see improved Modi-1 results in combination with CPI
- 3 Three biotech companies are negotiating re Glymabs/Avidimab atm*** ⭐
- Needle free is a big hit. Systemic administration (arm or leg ) gets at tumours in lungs and liver.
"
I don't believe those points I've highlighted with stars have had the debate they deserve i.e. "3 X biotech companies are negotiating" and "useful Active licensing discussions".
Surely quite significant?
Https://www.trinitydelta.org/research-notes/scib1-scope-study-shows-a-striking-82-orr/
Again, apologies if already posted? But headlines like '...striking 82% OOR' are significant IMO.
Think someone has already mentioned this, but another example of the increased high level(?) media exposure:
https://www.wsj.com/articles/scancell-ceo-hails-exciting-high-response-rate-to-melanoma-treatment-e913cd96
Bravo gf123, great post.
I'm not sure if you want to include 'hitman for hire' buttcrack in your CON list.
"...and yet another subtle de-ramp by Crumbs"
Exactly.
Crumbs, I think it's fair to say whatever you post now is taken with huge amount of salt. A tarnished reputation perhaps.
I said at the time, the motive behind anyone's post is as important as what's written in the actual post.
I just feel sorry for those that were panicked into selling, wether they interpreted the posts correctly or not, plus the likes of crackin trying to additionally stir the pot/kick the share price when it was down.
Https://www.linkedin.com/pulse/bracing-impact-bms-faces-steepest-patent-cliff-history-paul-shaw
...to add to inanacos and my post yesterday, how can BMS not be interested?
"20/9/2023
07:11 inanaco: i don't think folks have fully comprehended the significance and opportunity that this gives to the immunobody platform
Lindy is a diamond .....
Read Full ThreadFollowReply
20/9/2023
07:02 inanaco: just remember keytruda ... is linking arms with moderna to create the competitive advantage
but its short lived as i feel vaccines like scib1 will reduce market share considerably against personalised vaccine but a market will still exist .....
but can moditope break that market ? those that fail iscib1 ..... and could potentially be given a personal vaccine .... instead be given a moditope combo ?
fascinating to finally see what cutting edge vaccines can achieve
and surely Big Pharma must now look at the Covid vaccine
Read Full ThreadFollowReply
20/9/2023
06:35 inanaco: something Lindy said about patient numbers ............
because the efficacy is so high we don't need as many patients to prove up the data
that would also apply to the registrational trial
jt may be possible that Scancell could go it alone ...
however i suspect Bristol Myers to be very interested in bringing the treatment in house as they also have new products entering the market that would also have synergy
interesting times ......... but patient numbers go down on trial to achieve statistical evidence .... value increases
and we are talking big numbers,"
Agree, odd it's barely moved one way or another from around 20-23% most of the day.
...just an observation 🥸
Has someone got a link to the replay?
LD "...the data is so strong"
Just to add, you'd think there has already been some "courting" if you will, RE big pharma? So will be a case of now "we're all set, let's go"?
Were they waiting for the new business development officer (and CFO) to be in place before announcing today's data I wonder?
Yes exactly Dracula, the question is how long dare big pharma wait.
Data is now out, deal makers in place, conferences booked.
"Tumour reduction at 37 weeks.. 87% to 94%"
This needs re-emphasising/reiterating as much as possible IMO.
IMO we cannot also forget the all important 'Patent cliffs' that the big pharma are facing and need to tackle ASAP.